September 2026 Non-Life Premium: Health Up 27%, Crop Down, Multiline Insurers Up 12%. What H1 FY27 Means for Commercial Renewals

The September 2026 premium data, reported by Business Standard on 8 October 2026, puts non-life insurers' gross direct premium for the month at about Rs 32,951 crore, up 6 percent year on year. Read alone, that looks like a slowdown from August, when the industry grew 10 percent to Rs 27,455 crore on the back of health (per Free Press Journal reporting in September 2026).

The segment split says otherwise. Multiline general insurers grew 12.4 percent in September and standalone health insurers grew 27.1 percent. The industry total was pulled down because premium at Agriculture Insurance Company of India (AIC) came in lower than a year earlier. Crop premium is lumpy: it moves with scheme calendars and state government remittances, not with commercial demand.

For a commercial buyer, that distinction matters. The 6 percent headline is held down by crop. The figure closer to the insurers you will actually negotiate property, engineering, liability and marine renewals with is the 12.4 percent multiline number, which is in double digits, though it also includes those insurers' retail health and motor books.

For April to September FY27, non-life premium rose 8.92 percent to about Rs 1.80 trillion. Standalone health insurers grew 30.69 percent to about Rs 25,586 crore over the half year. Specialised insurers, the category that includes AIC and ECGC, fell 51.11 percent.

Set that against ICRA's June 2026 outlook, which projected FY2027 industry GDPI growth of 9.6 to 10.4 percent. At 8.92 percent, the first half is running slightly below the bottom of that range. ICRA's own framing explains part of the gap: it expected health momentum to be partly offset by pricing pressure in commercial lines.

What the half year tells a buyer

• Growth is concentrated. Standalone health is compounding at about 30 percent while specialised insurers have halved, so the industry average sits between two extremes and describes neither.
• Multiline insurers are the middle of the distribution, and their September print of 12.4 percent suggests they are still adding premium at a healthy clip.
• The second half has to run faster than the first for the industry to reach ICRA's band. That is the backdrop for the October to March renewal season.

This is the same pattern we described in the July data, where health and motor carried the industry while fire contracted. See how that mix shift should shape a renewal panel.

One caution before reading too much into the multiline number. Year-on-year growth is a ratio, and its denominator is the same month a year earlier. The September 2026 figure of Rs 32,951 crore at 6 percent growth implies a September 2025 industry figure of roughly Rs 31,000 crore, and anything unusual written or deferred in that month moves this year's growth rate without saying anything about current appetite.

Monthly prints also swing with timing. The industry grew 10 percent in August and 6 percent in September, while the half year ran at 8.92 percent. Crop remittances, the renewal dates of large group health and corporate property accounts, and one-off government business all land in particular months. The September release does not give a half-year growth figure for multiline insurers, so whether 12.4 percent is a new run rate or a strong single month cannot be read from September alone.

The practical consequence: an insurer that posts 13 or 14 percent growth in one month is not necessarily accelerating. It may be lapping a weak comparison or booking a large renewal. Ask your broker for six-month figures before treating a monthly print as a signal of appetite.

The insurer-level figures for September 2026 vary widely:

• SBI General Insurance: premium up 37 percent to Rs 1,673.25 crore.
• ICICI Lombard: premium up 13.7 percent.
• Bajaj General Insurance: gross direct premium of about Rs 2,363 crore, up 6.5 percent.
• Care Health Insurance (standalone health): premium up 44 percent to Rs 1,041.64 crore.

A CFO shortlisting insurers for a property or engineering programme should resist ranking these by growth rate. Three questions sort the signal from the noise.

1. Where is the growth coming from? An insurer growing fast on retail health or motor is not necessarily adding commercial property capacity. Ask for the line-of-business split, not the total.
2. Is the growth priced or bought? Fast premium growth in commercial lines during a period of pricing pressure can mean the insurer is winning on rate. That helps you at renewal and can hurt you at claim time if the book later needs correcting.
3. What is the base? SBI General's 37 percent took it to Rs 1,673.25 crore for the month, still below Bajaj General's Rs 2,363 crore after 6.5 percent growth. A high rate on a smaller book and a modest rate on a larger one describe different insurers, so compare absolute premium and the commercial share of it, not just percentages.

Monthly premium is a lead indicator, not a credit rating. Pair it with the solvency and claims data covered in our note on using monthly insurer data for counterparty monitoring.

Multiline insurers growing at 12.4 percent in a month, against an industry outlook that flags commercial pricing pressure, points to a market where insurers want premium and are willing to compete for it. For buyers renewing between October and March, that generally means:

• More quotes per risk. Insurers chasing growth targets in the second half tend to quote more aggressively on clean property and engineering risks with good loss history.
• Pressure on rates, not on terms first. Competition usually shows up as lower rates before it shows up as broader wordings. Buyers who want better terms (higher sub-limits, narrower exclusions, better reinstatement value basis) should ask for them explicitly rather than taking the rate cut alone.
• Differentiation by occupancy. Appetite is not uniform. Risks with poor fire protection, high catastrophe exposure or adverse claims history will not benefit from the same softness.

Engineering is worth separate attention. Premium growth across insurers in that line has been uneven, and capacity for large project risks depends heavily on reinsurance support. Our analysis of engineering premium divergence and project capacity covers how to test whether a lead insurer's appetite will hold for the full project period.

The H1 numbers leave the industry slightly behind ICRA's full-year range. Insurers that want to close the year near plan have two levers: grow retail lines faster, or write more commercial premium. Both are likely to be used, and the second creates negotiating room for corporate buyers.

That room comes with a caveat. ICRA's own outlook named pricing pressure in commercial lines as a drag on the year. Rate softness that is driven by growth targets rather than by improving loss experience tends not to last. Buyers who lock in this year's rate on a one-year policy should plan for the possibility that the next renewal reprices, particularly if insurer combined ratios deteriorate. We covered that pattern in combined ratio pressure and pricing discipline.

The buyers who benefit most from a competitive season are the ones who arrive with clean, current underwriting data: updated values, risk inspection reports, loss runs and protection upgrades documented. Insurers price uncertainty, and good submissions remove it.

Translating the September 2026 release into actions for a commercial programme renewing between now and March:

1. Use multiline, not industry, growth as your market reference. The 12.4 percent multiline figure describes your counterparties; the 6 percent industry figure includes crop swings that have nothing to do with your risk.
2. Ask for line-level data on each panel insurer. Total premium growth at SBI General, ICICI Lombard or Bajaj General tells you little about their fire, engineering or liability books specifically.
3. Check six months, not one. Compare each insurer's April to September growth with the industry's 8.92 percent, and treat September alone as a directional check, since monthly prints swing with base and renewal timing.
4. Run a competitive process on clean risks. Double-digit multiline growth suggests insurers will quote. Approach more than the incumbent if your loss record supports it.
5. Trade rate for terms where you can. Lock in wording improvements while insurers are competing for premium.
6. Watch the second-half data. If commercial pricing pressure continues and loss ratios rise, expect correction at the FY28 renewal cycle.

For panel construction itself, our guide to insurer panel diversification and concentration risk sets out how many insurers to use and how to split shares.